Publication

Collection, access and use of human genetic information for precision medicines: Risk governance considerations

Marie-Valentine Renée Agnès Florin
2016
Reports

Abstract

Gene technologies and their application by industry are developing rapidly, particularly in the US and in China. Yet, governance of the field of genomic for precision medicine is developing more slowly and needs to catch up. The rapid developments in science and technology but also in how cultures and values consider questions of ethics, privacy and data protection, pose challenges to regulators and policymakers. This report summarises some of the discussions at a workshop in August 2015.

Official source

https://infoscience.epfl.ch/entities/publication/cca74093-5770-43d8-a6e2-17d9ef4b543f

About this result

This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.

Graph Chat

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Collection, access and use of human genetic information for precision medicines: Risk governance considerations

Chat with Graph Search

The dynamic genetic determinants of increased transcriptional divergence in spermatids

Identifying genetic and dietary modulators of metabolic disorders using systems genetics

Neural ADMIXTURE for rapid genomic clustering